Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Levetiracetam Injection, USP Due to Lack of Sterility Assurance

November 19, 2021 | Food and Drug, Recalls

Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of four lots of Levetiracetam Injection, USP, to the user level. The lack of container closure integrity, found in reserve sample vials may result in a non-sterile product
Go to Source

Tags:

Comments are closed.

Flickr Digg Yahoo! Technorati MySpace Delicious RSS